ABVD scheme

The ABVD regimen is a chemotherapy regimen for Hodgkin's disease with a specific selection of cytostatic agents in four double cycles. The application is possible on an outpatient basis.

A driamycin	25 mg / m²	iv	Day 1 + 15
B leomycin	10 mg / m²	iv	Day 1 + 15
V inblastin	6 mg / m²	iv	Day 1 + 15
D acarbazine	375 mg / m²	iv	Day 1 + 15

(mg / m² = amount / body surface / day)

Since it through the use of dacarbazine excessive vomiting may occur, should always be - a - prophylactically to prevent a conditioning antiemetic from the group of 5-HT ₃ receptor blockers ( Setrone be given).

literature

• G. Bonadonna, R. Zucali, S. Monfardini, M. De Lena, C. Uslenghi: Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. In: Cancer. 36 (1), Jul 1975, pp. 252-259. PMID 54209

This article is about a health issue. It is not used for self-diagnosis and does not replace a diagnosis by a doctor. Please note the information on health issues !